IESE (España)
-
Carrefour Group: Growth Management
Roig, Guillem; Rahnema Alavi, Ahmad; Vergara, CarlesCase F-909-EFinanceOn November 13, 2014, Roberto Alonso, investment manager at Alpha Funds, received a report from his research team regarding the Carrefour Group. Alpha was interested in the distribution sector for several reasons. First, the sector is especially defensive against market uncertainty, since it deals with basic necessities. Thus, while the international markets may experience large fluctuations, the fund would have relatively little exposure to thes...Starting at €8.20
-
BioRecilGent (B)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-381-EDecision AnalysisThe case focuses on the development of a yet-to-be-approved drug. It presents the various options open to the company developing the drug in the context of the phases that the medicine must go through to be approved.Starting at €5.74
-
BioRecilGent (A)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-380Decision AnalysisEl caso presenta el desarrollo de un fármaco que todavía no está aprobado. Muestra las distintas opciones que tiene la empresa que lo desarrolla, según las diferentes fases para su aprobación.Starting at €8.20
-
Balkan Snack Foods, d.d.
Roig, Guillem; Rahnema Alavi, AhmadCase F-916-EFinanceThe structure of Balkan Snack Foods allows for an analysis of financing costs depending on the choice between different currencies. Such an analysis entails measuring the exchange rate risk as well as its impact on the company's financing costs and bottom line. It also involves an examination of the relationship between the company's competitive position and the type and form of financing it chooses.Starting at €8.20
-
BioRecilGent (B)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-381Decision AnalysisEl caso presenta el desarrollo de un fármaco que todavía no está aprobado. Muestra las distintas opciones que tiene la empresa que lo desarrolla, según las diferentes fases para su aprobación.Starting at €5.74
-
BioRecilGent (A)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-380-EDecision AnalysisThe case focuses on the development of a yet-to-be-approved drug. It presents the various options open to the company developing the drug in the context of the phases that the medicine must go through to be approved.Starting at €8.20
-
Grupo Carrefour: gestión de crecimiento
Roig, Guillem; Rahnema Alavi, Ahmad; Vergara, CarlesCase F-909FinanceEl 13 de noviembre de 2014, Roberto Alonso, gestor de inversiones en Alpha Funds, recibió un informe de su equipo de investigación referente al Grupo Carrefour. Alpha estaba interesada en el sector de la distribución por varias razones. En primer lugar, el sector es especialmente defensivo frente a la incertidumbre de los mercados, ya que trata con bienes de primera necesidad. Así, aunque los mercados internacionales experimentaran grandes fluctu...Starting at €8.20